Comments
Loading...

Ikena Oncology

IKNANASDAQ
Logo brought to you by Benzinga Data
$1.66
-0.01-0.60%
At Close: -
$1.69
0.031.81%
After Hours: Sep 11, 6:19 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$22.00
Lowest Price Target1
$2.00
Consensus Price Target1
$10.25

Ikena Oncology (NASDAQ:IKNA) Stock, Analyst Ratings, Price Targets, Forecasts

Ikena Oncology Inc has a consensus price target of $10.25 based on the ratings of 4 analysts. The high is $22 issued by HC Wainwright & Co. on March 17, 2023. The low is $2 issued by Wedbush on May 29, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Wedbush, and HC Wainwright & Co. on August 12, 2024, May 29, 2024, and May 29, 2024, respectively. With an average price target of $3.33 between HC Wainwright & Co., Wedbush, and HC Wainwright & Co., there's an implied 97.24% upside for Ikena Oncology Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
1
1
May
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Wedbush
Credit Suisse
HC Wainwright & Co.

1calculated from analyst ratings

Analyst Ratings for Ikena Oncology

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Ikena Oncology (IKNA) stock?

A

The latest price target for Ikena Oncology (NASDAQ:IKNA) was reported by HC Wainwright & Co. on August 12, 2024. The analyst firm set a price target for $4.00 expecting IKNA to rise to within 12 months (a possible 136.69% upside). 10 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Ikena Oncology (IKNA)?

A

The latest analyst rating for Ikena Oncology (NASDAQ:IKNA) was provided by HC Wainwright & Co., and Ikena Oncology reiterated their buy rating.

Q

When was the last upgrade for Ikena Oncology (IKNA)?

A

There is no last upgrade for Ikena Oncology

Q

When was the last downgrade for Ikena Oncology (IKNA)?

A

The last downgrade for Ikena Oncology Inc happened on May 29, 2024 when Wedbush changed their price target from $8 to $2 for Ikena Oncology Inc.

Q

When is the next analyst rating going to be posted or updated for Ikena Oncology (IKNA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ikena Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ikena Oncology was filed on August 12, 2024 so you should expect the next rating to be made available sometime around August 12, 2025.

Q

Is the Analyst Rating Ikena Oncology (IKNA) correct?

A

While ratings are subjective and will change, the latest Ikena Oncology (IKNA) rating was a reiterated with a price target of $4.00 to $4.00. The current price Ikena Oncology (IKNA) is trading at is $1.69, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch